101
Participants
Start Date
March 30, 2017
Primary Completion Date
December 4, 2019
Study Completion Date
December 4, 2019
Tocilizumab
For intravenous (IV) tocilizumab, the recommended dosage is 8 milligrams per kilogram (mg/kg) once every 4 weeks. For subcutaneous (SC) tocilizumab, the recommended dosage is 162 milligrams (mg) once weekly. However, because of the observational nature of the study, dosing and treatment duration is at the discretion of the physician in accordance with local clinical practice and local labeling.
Glucocorticoid Agent
Because of the observational nature of the study, the choice of glucocorticoid agent, as well as dosing and treatment duration, is at the discretion of the physician in accordance with local clinical practice and local labeling.
CHU St Pierre (César de Paepe), Brussels
Hospital Erasme, Brussels
Rhumarc sciv sprl, Céroux-Mousty
AZ Turnhout Sint Jozef, Turnhout
AZ Sint Jozef Malle, Westmalle
Heilig Hartziekenhuis vzw, Lier
UZ Antwerpen, Edegem
Private Practice; Reumatologie, Mechelen
Private Practice Els Van Essche, Bonheiden
Reumacentrum Genk, Genk
Reumaclinic, Genk
CHC MontLégia, Liège
CHU de Liège; Rhumatologie, Liège
Dr. Huppertz - Marx pgmbh, Amel
GHdC Site Saint-Joseph, Gilly (Charleroi)
Rhumaconsult sciv sprl; Private Practice, Forchies-la-Marche
AZ Sint Jan, Bruges
AZ Alma vzw (Sijsele), Sijsele
AZ Damiaan, Ostend
AZ Sint Lucas (Sint Lucas), Ghent
ASZ Aalst, Aalst
Onze Lieve Vrouwziekenhuis Aalst, Aalst
Hoffmann-La Roche
INDUSTRY